TVM Capital — 2017 Investments
1 investments dated 2017 · listed companies and verified rows first · show all
Acer TherapeuticsSep 2017SEC filingmedium confidence
BiotechCambridge, US
Christopher Schelling(Executive Officer, Director, Promoter)Harry S. Palmin(Executive Officer, Director, Promoter)
BoardCynthia Lavoie(Director)
Board seatHubert Birner· per SEC Form D · $15.7M raise · filed Oct 2017
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.